HYMSEVA owner Contact Information online
from SANOFI
HYMSEVA
US serial number:85097171
Application filling date:Jul. 30, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Mar. 29, 2011
Publication date:Jan. 11, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign foreign registration number:02/3178537
Foreign foreign registration date:Aug. 06, 2002
Foreign foreign application registration country:FRANCE
Foreign foreign expiration date:Aug. 06, 2012
Goods and services:For: pharmaceutical preparations for the treatment of cardiovascular diseases
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 44(e)
Services:pharmaceutical preparations for the treatment of cardiovascular diseases
Current owner owner name:SANOFI
Current owner owner address:54 rue La Boétie
Paris
FRANCE
75008
Current owner legal entity type:SOCIETE ANONYME
Current owner state or country:FRANCE
Attorney name:Susan Upton Douglass
Attorney email:sdouglass@frosszelnick.com
Attorney docket number:SYN 1005258
Attorney email authorized:No
Correspondent name address:SUSAN UPTON DOUGLASS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK,
NEW YORK
UNITED STATES
10017-1822
Correspondent phone:212-813-5900
Correspondent email:sdouglass@frosszelnick.com
Correspondent fax:212-813-5901
Correspondent email authorized:No
Domestic representative name:Susan Upton Douglass
Domestic representative phone:212-813-5900
Domestic representative fax:212-813-5901
Domestic representative email:sdouglass@frosszelnick.com
Domestic representative email authorized HYMSEVA:Yes
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (132) JOHNSON & JOHNSON (125) SANOFI (60) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) Sears Brands, LLC (24) MONSTER ENERGY COMPANY (19) Scott Riddell (17)Popular publication dates
Jan. 11, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Apr. 19, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Feb. 22, 2011 Jan. 25, 2011 Sep. 21, 2010 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011
